Infinimmune Alternatives & Competitors

12 companies similar to Infinimmune — Treating human disease with truly human therapeutics.

Ability Biotherapeutics

Developing innovative targeted immuno therapeutics to addressing unmet medical needs for c...

25 Seed $30.00M

Montreal, Canada

Biotechnology Life Sciences

Tradewind BioScience

Innovative therapeutics for the most aggressive cancers

5 Seed $120.00K

United States

Biotechnology Health Care

Cidara Therapeutics

Leading the Science of Protection

47 Acquired $10.41B

San Diego, United States

Biotechnology Health Care +1

Merus N.V.

Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community...

185 Post-IPO Equity $1.04B

Utrecht, The Netherlands

Biotechnology Health Care +1

Track all Infinimmune competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Mestag Therapeutics

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

40 Seed $11.00M

London, United Kingdom

Biotechnology Health Care +1

Immunitas Therapeutics

The Human Approach to Oncology

33 Series B $97.00M

Waltham, United States

Biotechnology Health Care +2

Oxford BioTherapeutics

Redefining the cancer-immune synapse for novel immune checkpoint mechanisms

66 $28.09M

Oxford, United Kingdom

Biotechnology Health Care +1

NextPoint Therapeutics, Inc.

Launching a new world of precision therapeutics through its leading scientific work on th...

38 $122.48M

Biotechnology Health Care +2

Serimmune Inc.

Mapping Human Immunity - Generating Insights to Improve Health

13 Venture round $21.45M

Goleta, United States

Biotechnology Health Care +1

DEM Biopharma, Inc.

Novel Target for Solid Tumors

20 $70.00M

Cambridge, United States

Biotechnology Life Sciences +1

Augmenta Bioworks, Inc.

Profiling individual immunity for global therapeutics

Menlo Park, United States

Biotechnology Health Care +1

Myosin Therapeutics Inc.

Developing next generation therapeutics targeting molecular motors

8 Seed $3.00M

Jupiter, United States

Biotechnology Health Care +1

About Infinimmune

Infinimmune is a promising startup in the biotechnology and healthcare industries, founded in 2022. The company's mission, as reflected in its slogan "Treating human disease with truly human therapeutics," is to revolutionize the treatment of human diseases. In December 2022, Infinimmune secured a significant $12.00M S...

Business keywords

Antibody Discovery, Therapeutics, Human Immune System, Drug Development

Frequently Asked Questions

Companies similar to Infinimmune include Ability Biotherapeutics, Tradewind BioScience, Cidara Therapeutics, Merus N.V., Mestag Therapeutics. They work in Biotechnology and Health Care and share Infinimmune's focus on therapeutics, drug development and antibody discovery.

Bounce Watch lists 12 companies that share Infinimmune's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Infinimmune and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Infinimmune Profile Ability Biotherapeutics Alternatives Tradewind BioScience Alternatives Cidara Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Infinimmune on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.